Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 31Myelodysplastic Syndromes 26Multiple Myeloma 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia 19Lymphoma 18Hodgkin Disease 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Lymphoma, Non-Hodgkin 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Large B-Cell, Diffuse 10Hematologic Neoplasms 9Primary Myelofibrosis 8Leukemia, Myelomonocytic, Chronic 8Graft vs Host Disease 8Myeloproliferative Disorders 7Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Leukemia, Myelomonocytic, Juvenile 5Recurrence 4Neoplasms 4Lymphoma, T-Cell 4Lymphoma, B-Cell, Marginal Zone 4Burkitt Lymphoma 4Breast Neoplasms 4Anemia, Aplastic 4Polycythemia Vera 3Lymphoma, Mantle-Cell 3Leukemia, Biphenotypic, Acute 3Hemoglobinuria, Paroxysmal 3

Interventions

Temozolomide 73Bevacizumab 58Radiotherapy 40Radiosurgery 28Carboplatin 23Nivolumab 17Etoposide 17Cisplatin 17pembrolizumab 16Irinotecan 16Ipilimumab 15Magnetic Resonance Spectroscopy 14Erlotinib Hydrochloride 14Cyclophosphamide 14Carmustine 14Pemetrexed 13Topotecan 10Surgical Procedures, Operative 10Capecitabine 10Lapatinib 9Filgrastim 9Trastuzumab 8Thalidomide 8Sunitinib 8Paclitaxel 8Lomustine 8Aminolevulinic Acid 8encorafenib 7binimetinib 7Vincristine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Brain Neoplasms × Stem Cell Transplantation × Clear all
NCT00179803 2020-08-05

Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2 Completed
24 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Supratentorial Neoplasms, Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡